Medtronic Expands Health Equity Assistance Program for Colon Cancer Screening With Support From Amazon Web Services; Completes First Installation of Donated GI Genius™ Intelligent Endoscopy Modules

2022-07-23 08:16:03 By : Mr. xcellent corp

Additional +80 GI Genius™ units to be donated for a total of 133 to 62 facilities that primarily serve communities with low screening rates or where access to the technology is not currently available

DUBLIN, July 21, 2022 /3BL Media/ - Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and the American Society for Gastrointestinal Endoscopy (ASGE) today announced they are expanding the Medtronic Health Equity Assistance Program for colon cancer screening in medically underserved communities across the United States, with support from Amazon Web Services's (AWS) Health Equity Initiative. The GI Genius units provided as part of the program have increased from 50 to 133 systems being placed at 62 facilities.

Grady Memorial Hospital in Atlanta, Ga. was the first to receive its donated GI Genius units last month following the launch of the program in February 2022. Gastroenterologists at Grady Memorial Hospital perform more than 7,000 colon cancer screening procedures each year among a predominantly Black community. Accounting for 80% of the specialty's patient population, Black adults are disproportionately burdened by colon cancer, at greater risk of diagnosis, worse outcome and death.

"We are excited to provide this novel technology to our patients. By utilizing GI Genius, we have the potential to increase our adenoma detection rate and reduce the incidence of colorectal cancer in a high-risk and vulnerable population," said Benjamin D. Renelus, M.D., a gastroenterologist at Grady Memorial Hospital. "The hospital's hope is that the thousands of patients receiving colonoscopy cancer screenings each year at our facility will benefit from Medtronic's GI Genius intelligent endoscopy module with the potential for earlier detection and better patient outcomes."

"This endeavor is a unique and inspiring opportunity to contribute enormously to the reduction of colorectal cancer screening disparities in communities where patients are disproportionately uninsured and have historically faced barriers accessing life-saving preventative care, including healthcare technology that can aid in detecting colorectal cancer," said Fola May, M.D., Ph.D., associate professor of Medicine, director of Quality Improvement in Gastroenterology, and health equity researcher at UCLA Health.

"Equity in healthcare begins with ensuring access for all to life-transforming therapies," said Geoff Martha, Medtronic chairman and chief executive officer. "It's exciting to see how our new collaboration with AWS can help clinicians detect colon cancer early among some of the highest risk individuals in our country."

The GI Genius intelligent endoscopy module, authorized by the FDA in April 2021, is the first-to-market, computer-aided polyp detection system powered by artificial intelligence (AI) to detect colorectal polyps of varying shapes and sizes automatically in real time which helps diagnose and prevent colorectal cancer. In the first U.S. trial using GI Genius, results published this spring showed a 50% reduction in missed colorectal polyps with AI technology versus standard colonoscopy.

"This initiative is so important because we know that almost half of all cases of post-colonoscopy colon cancer may be attributed to not catching polyps during the index colonoscopy,"1,2 said Dr. Austin Chiang, M.D., M.P.H., chief medical officer of the Gastrointestinal business, which is part of the Medical Surgical Portfolio at Medtronic. "We have seen the impact that AI-assisted colonoscopies can have, and this study unequivocally demonstrates that this technology helps physicians better detect polyps during colonoscopies. The impact of missed polyps could ultimately be the difference between life and death when we consider that 90% of patients with colon cancer can beat it when it's caught early."3

The American Society for Gastrointestinal Endoscopy, who led the submission and selection process for this program, recently released their full list of recipients for donated GI Genius units.

About ASGESince its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with almost 15,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit Asge.org and ValueOfColonoscopy.org for more information.

About MedtronicBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

1Zhao S, Wang S, Pan P, et al. Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. Gastroenterology 2019;156:1661-1674.e112Robertson, D.J.; Lieberman, D.A.; Winawer, S.J.; Ahnen, D.J.; Baron, J.A.; Schatzkin, A.; Cross, A.J.; Zauber, A.G.; Church, T.R.; Lance, P.; et al. Colorectal Cancers Soon after Colonoscopy: A Pooled Multicohort Analysis. Gut 2014, 63, 949–956.3National Cancer Institute. Cancer stat facts: colon and rectum cancer. National Cancer Institute Website. http://seer.cancer.gov/statfacts/html/colorect.html. Accessed Feb. 7, 2017.

Contacts:Sabrina ZimringPublic Relations+1-720-774-3454

Ryan WeispfenningInvestor Relations+1-763-505-4626

View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/medtronic-expands-health-equity-assistance-program-for-colon-cancer-screening-with-support-from-amazon-web-services-completes-first-installation-of-donated-gi-genius-intelligent-endoscopy-modules-829045205

Target (TGT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Yesterday, Biogen Inc (NASDAQ: BIIB) reported Q2 earnings. Needham writes that while operational performance looked good, uncertainty looms over the company's growth potential. Lecanemab Phase 3 readout this fall should provide some clarity. The high-risk, high-reward event will impact the company's medium-term growth prospects. Needham still sees the base business plus risk-adjusted value of lecanemab as providing upside vs. current stock levels. It maintains the Buy rating but lowered the pric

The synthetic opioid, in all its forms, is the No. 1 drug being distributed in Charlotte, according to a CMPD narcotics officer.

The FDA bestows a Fast Track designation to Olema's (OLMA) novel pipeline candidate, OP-1250, for the treatment of ER+/HER2- metastatic breast cancer. Stock up.

The new COVID-19 variants are more transmissible than ever, but how different do symptoms look compared to a year ago?

As Amazon extends its tentacles further into the healthcare sector, many people are expressing their concerns about the One Medical deal.

Alzheimer's disease and other forms of cognitive decline present a devastating worldwide problem—and it's a condition that is steadily on the rise. According to Alzheimer's Disease International (ADI), there were over 55 million people living with dementia across the world in 2020, and that number is projected to reach 139 million by 2050. There is no known cure for dementia, making it essential to look for early symptoms of the disease in order to access treatment. The benefits of an early diag

Without obvious signs of contamination like the mold in this jam, consumers use expiration dates to decide whether to keep or throw away food. Ralf Geithe via iStock/Getty ImagesFlorida’s outbreak of listeria has so far led to at least one death, 22 hospitalizations and an ice cream recall since January. Humans get sick with listeria infections, or listeriosis, from eating soil-contaminated food, undercooked meat or dairy products that are raw, or unpasteurized. Listeria can cause convulsions, c

President Joe Biden’s speech at a former coal-fired power plant in Massachusetts led to widespread claims on social media that he made a significant announcement not about climate change, but about his health. Conservative politicians and political commentators focused on a clip from Biden’s Wednesday speech, in which he told a story about growing up near Delaware oil refineries, to assert that the president announced that he has cancer. In response, a White House spokesperson confirmed reports that Biden was referring to previously disclosed skin cancer that was removed before he became president — not announcing a new diagnosis.

The 6-year-old was bitten while at the Bluestem Prairie Open Space near Colorado Springs on July 5 and died Monday.

If you're suffering from arthritis, you're one of approximately 58.5 million people in the United States who deals with this disease (or 1 in every 4 adults). It is a leading cause of work disability, with more than half of U.S. adults (57.3%) with arthritis of working age between 18 to 64 years old.The good news is that there are ways to reduce its symptoms, which include pain, aching, stiffness, and swelling in or around the joints. Some examples are taking supplements, watching what you eat,

U.S. COVID cases and hospitalizations are rising again and are now trending at the highest level seen this summer so far, as the BA.5 omicron subvariant becomes dominant.

White House pandemic response coordinator Dr. Ashish Jha delivered a grim message on Friday about the ever-evolving coronavirus pathogen that the Centers for Disease Control and Prevention estimates has infected more than 140 million Americans, including President Biden.

Amazon's health care expansion plans, including its $3.9 billion acquisition of One Medical, shook health care stocks.

New Zealanders are dying from COVID-19 at record rates as the country battles a new wave of the Omicron strain that is particularly affecting the older population. Deaths from the virus reached 151 in the seven days to July 16, compared with 115 in the worst week of the previous wave, in March, according to Health Ministry data. In the latest 24 hours, 26 people died from COVID, all aged over 60, the ministry said in a statement on Friday.

People may not normally have noticed an 11-year-old girl, but no one could overlook when her belly grew fatter and fatter, Amelia Robinson writes.

A recent study has found that Bay Area residents of Asian descent were more likely to be hospitalized with COVID-19 than any other racial or ethnic group in the area in 2020. The research, co-authored by a University of California, San Francisco, researcher and published in the Journal of Racial and Ethnic Health Disparities on Tuesday, noted that the heightened risk among Asians cannot be fully explained by socioeconomic factors or pre-existing medical conditions. While the study also included Black, Hispanic and white residents, Asians were the only racial group whose age, income, health insurance status and medical comorbidities did not fully account for their higher risk of hospitalization.

BA.5 is changing the game when it comes to multiple COVID-19 infections. This is what experts know about how long immunity lasts now.

The 67-year-old woman was airlifted from Portland in the US to Chennai in India for surgery.

Florida is facing several disease outbreaks — COVID, monkeypox, dengue fever. But meningococcal disease is now on the minds of health experts, too.